However, patients with S-IGF-1 in the highest quartile (Q4; corresponding to >1.09 × ULN) showed a significantly higher risk of sleep apnea (48%) compared to patients with S-IGF-1 in Q1–Q3 (32%) (p = 0.021). Here, IGF1 is linked to sleep apnea syndrome.